WA
LYEL icon

WuXi AppTec’s Lyell Immunopharma LYEL Stock Holding History

WuXi AppTec’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$10.2M Sell
369,536
-14,572
-4% -$428K 53.56% 1
2024
Q2 		$11.1M Sell
384,108
-24,926
-6% -$1.19M 47.74% 2
2024
Q1 		$18.2M Hold
409,034
– – 62.06% 1
2023
Q4 		$15.9M Buy
+409,034
New +$14.7M 41.15% 1

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WuXi AppTec's LYEL Position: Q3 2024 in Review

WuXi AppTec reduced its Lyell Immunopharma (LYEL) stake by 3.8% in Q3 2024, selling an estimated $428K and leaving 369,536 shares worth $10.2M. The position accounts for 53.56% of the portfolio, ranked #1.

WuXi AppTec first reported a position in LYEL in Q4 2023 and has held it in 4 quarters since. The position peaked at $18.2M in Q1 2024. 117 funds tracked by Wall St. Rank hold LYEL as of Q3 2024.

  • WuXi AppTec held 369,536 shares of Lyell Immunopharma worth $10.2M as of Q3 2024.
  • WuXi AppTec sold 14,572 Lyell Immunopharma shares in Q3 2024, an estimated $428K.
  • Lyell Immunopharma made up 53.56% of WuXi AppTec's portfolio in Q3 2024, its #1 holding.
  • WuXi AppTec first reported a position in Lyell Immunopharma in Q4 2023 and has held it in 4 quarters since.
  • WuXi AppTec's Lyell Immunopharma position peaked at $18.2M in Q1 2024.
  • 117 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2024.

Based on WuXi AppTec's 13F filing for Q3 2024, filed 8 Nov 2024.